Project description
Novel software for better minimally invasive cancer treatment
GoSmart is a novel cloud-based software that will train radiologists on image-guided minimally invasive cancer treatments and help them plan the optimal treatment of patients without any risk in a virtual setting. This will result in more precise therapy and more efficient and cost-effective processes while lowering hospitals’ carbon footprint by working together and minimising travel. In addition, this simulation environment will enable less experienced clinicians to collaborate with their colleagues around the world. The EU-funded SIMCARE project aims to introduce the software to the market by performing a feasibility study to understand the technical and commercial requirements. Moreover, it will analyse market needs and define regulatory needs.
Objective
The objective of this proposal is to assess the potential for commercialisation of an innovative cloud-based software product which will assist interventional radiologists to perform minimally invasive cancer treatments more successfully. There are different approaches to removing tumours in organs (i.e. the liver, kidney and lung) and each has its own advantages and disadvantages, depending on the size and location of the tumour. Minimally invasive cancer treatments offer clear advantages as the procedures are targeted and much less intrusive compared to surgical resection. However, the procedure can be very technical, as the radiologist must understand how the settings of the device affect the heat transfer in the localised region surrounding the tumour. Our software product will bridge this gap and help the radiologist understand how to best perform the treatment within a virtual environment with no risk to the patient. This will bring benefits to the radiological community through more accurate treatments, will make the procedures more efficient and cost-effective, and will reduce the hospital carbon footprint through more integrated collaboration and reduced travel. In addition, as it is web-based, it will help to integrate the global interventional oncology community, providing less experienced clinicians in developing countries with a user-friendly environment to work with their more experienced colleagues on a global basis. During this project, we will enhance our simulation environment and refine our growth projections for the first 8 years on the market. We will also analyse the market needs and define the regulatory requirements for patient data sharing and use of the software in the clinical environment. This information will assist us to understand the most efficient route to bring the software to the market.
Fields of science
- medical and health sciencesclinical medicinesurgery
- medical and health sciencesclinical medicineradiology
- medical and health sciencesclinical medicineoncology
- engineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imaging
- natural sciencescomputer and information sciencessoftwaresoftware applicationssimulation software
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
A91 Dundalk Louth
Ireland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.